| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.3M | +550.0% |
| R&D Expense | $113.0M | -44.5% |
| SG&A Expense | $23.3M | -81.8% |
| Operating Income | -$135.0M | +59.3% |
| Pre-tax Income | -$140.1M | -108.3% |
| Income Tax | $2K | +0.0% |
| Net Income | -$140.1M | -108.3% |
| EPS (Basic) | -$9.04 | -107.9% |
| EPS (Diluted) | -$9.04 | -108.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $124.2M | -18.6% |
| Current Assets | $132.8M | -17.2% |
| Total Assets | $146.5M | -19.0% |
| Current Liabilities | $33.8M | -17.0% |
| Long-term Debt | $100.6M | — |
| Total Liabilities | $138.5M | +193.5% |
| Stockholders' Equity | $8.0M | -94.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$129.8M | +33.2% |
| Capital Expenditures | $31K | -98.8% |
| Investing Cash Flow | -$28K | +98.9% |
| Financing Cash Flow | $101.4M | +41.5% |
| Free Cash Flow | -$129.8M | +34.1% |